文献速递主动脉疾病

开窗与分支腔内移植物下方倒置分支构型的早期与中期结果:来自两家欧洲中心的经验

Early and Mid-Term Outcomes of the Inverted Limb Configuration Below Fenestrated and Branched Endografts: Experience from Two European Centers.
PubMed 文献 · J Endovasc Ther · 2022-10-02

该研究回顾性分析2016至2020年两家欧洲大学中心41例高危患者,因既往开放或腔内修复或肾下主动脉长度<76 mm,在开窗与分支腔内主动脉修复(FB-EVAR)远端使用倒置分支(IL)治疗近/肾旁腹主动脉瘤、胸腹主动脉瘤及吻合口旁主动脉瘤。技术成功率97.6%(40/41),30天死亡率为0%;30天并发症2例(4.9%)。平均随访21±16个月,髂动脉并发症3例(7.3%),靶内脏血管通畅率96.8%。结论认为IL构型可安全地对高危患者 challenging 主动脉病变行腔内治疗,但需多种辅助操作;IL主体过短可能与术中及围术期III型内漏相关。

要点

  • 41例高危患者FB-EVAR远端使用倒置分支,技术成功率97.6%(40/41),30天死亡率为0%。
  • 30天并发症2例(4.9%):1例肢体闭塞需再干预,1例III型内漏自行缓解。
  • 平均随访21±16个月,髂动脉并发症3例(7.3%),靶内脏血管通畅率96.8%。

核心结论

  • IL构型使高危患者的困难主动脉病变能够获得安全的腔内治疗,尽管需要多种辅助操作。
  • IL主体过短可能与术中及围术期III型内漏相关。

研究设计与样本

  • 回顾性分析2016至2020年两家欧洲大学中心所有因既往开放修复或腔内修复或肾下主动脉长度<76 mm而在FB-EVAR远端使用IL的病例。
  • 共纳入41例高危患者,其中近/肾旁腹主动脉瘤8例(19.5%)、胸腹主动脉瘤33例(80.5%)。
  • 16例(39%)有既往主动脉治疗史(开放修复8例、EVAR 8例)。
  • 定制腔内移植物构型为:单纯开窗31例(75.6%)、单纯分支6例(14.6%)、开窗+分支4例(9.8%),共158条靶内脏血管(每例3.8±0.7条)。
  • IL主体计划为1支架6例(14.6%)、2支架23例(56.1%)、3支架12例(29.3%)。

主要发现

  • 技术成功率为97.6%(40/41),30天死亡率为0%。
  • 30天并发症2例(4.9%):1例肢体闭塞需再干预,1例III型内漏自行缓解。
  • 30天后髂动脉并发症3例(7.3%),包括2例闭塞和1例Ib型内漏,均经腔内再干预成功处理;未观察到IL相关并发症。
  • 靶内脏血管通畅率为96.8%。
  • 除1支架IL与III型内漏相关(log rank p=0.01)外,解剖特征、腔内移植物构型与主要结局之间未观察到相关性。

临床怎么用

  • 原文结论认为IL构型可安全地对高危患者的困难主动脉病变行腔内治疗,尽管需要多种辅助操作。
  • 原文结论指出IL主体过短可能与术中及围术期III型内漏相关。
  • 原文临床影响部分指出,倒置分支构型提高了全腔内方法在困难解剖患者中的可行性,可克服短主体初始移植物及最低靶动脉与主动脉分叉间距离短的解剖限制,将固定点置于移植物内部。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report a European experience on the use of the Inverted Limb (IL) below fenestrated and branched endografts (FB-EVAR) for the treatment of juxta/pararenal (JP-AAAs), thoracoabdominal (TAAAs), and para-anastomotic aortic aneurysms. MATERIALS AND METHODS: Between 2016 and 2020, all FB-EVAR with distal IL due to previous open (OSR) or endovascular repair (EVAR) or infrarenal aortic length <76 mm at two European university centers were retrospectively analyzed. Technical success, early and mid-term iliac complications (occlusion; type Ib endoleak [EL]), IL-related complications (type III EL), and reinterventions were assessed as primary endpoints; 30-day mortality, survival and freedom from (FF) overall complications/reinterventions were assessed as secondary outcomes. RESULTS: Forty-one high-risk patients (male 30%-73%; mean age 71±10 years; ASA 3-4, 41%-100%) underwent FB-EVAR with distal IL for 8 (19.5%) J/P-AAAs and 33 (80.5%) TAAAs. Sixteen (39%) patients with previous aortic treatment (8 OR, 8 EVAR) were included. Preoperative computed tomographic angiography showed infrarenal aortic length <76 mm in all cases. Custom-made endografts were configured as 31 (75.6%) fenestrated-only, 6 (14.6%) branched-only, and 4 (9.8%) fenestrated+branched for an overall of 158 target visceral vessels (TVVs; 3.8±0.7 TVVs/case). The IL main body was planned with 1-stent, 2-stents, and 3-stents in 6 (14.6%), 23 (56.1%), and 12 (29.3%) cases, respectively. Technical success and 30-day mortality were 97.6% (40/41) and 0%. Thirty-day complications occurred in 2 (4.9%) patients: 1 limb occlusion, requiring reintervention, 1 type III EL, spontaneously resolved. Mean follow-up was 21±16 months. Three After 30-day, 3 (7.3%) iliac complications (2 occlusions; 1 type Ib EL) were successfully managed by endovascular reinterventions; no IL-related complications were observed. The patency of TVVs was 96.8%. No correlation between anatomical characteristics, endograft configuration, and primary outcomes was observed, except for 1-stent IL and type III EL (log rank p=0.01). At 1- and 2-year follow-up survival, FF overall iliac/IL-related complications and FF reinterventions were 90% and 80%, 90% and 84%, and 92% and 87%, respectively. CONCLUSION: The IL configuration allows a safe endovascular treatment of challenging aortic lesions in high-risk patients although needing a number of adjunctive procedures. A short main body of IL could be associated with intraoperative and perioperative type III EL. CLINICAL IMPACT: Bifurcated endograft with inverted limb configuration increases the feasibility of a total endovascular approach in patients with challenging anatomy. The use of inverted limb overcomes the anatomical limitations of short-body initial grafts and short distance between lowest target artery and the aortic bifurcation, leading the fixation inside the endograft. Although technically demanding, this advanced technology could avoid surgical reinterventions in previous open or endovascular repair that are burdened with higher rates of morbidities and complications.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Fenelli C, Tsilimparis N, Faggioli G, et al. Early and Mid-Term Outcomes of the Inverted Limb Configuration Below Fenestrated and Branched Endografts: Experience from Two European Centers. J Endovasc Ther. 2022. PMID: 36189939. doi:10.1177/15266028221125158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。